These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 3295549)

  • 21. Elevated serum tryptase levels in a patient with protracted anaphylaxis.
    Vinuya RZ; Simon MR; Schwartz LB
    Ann Allergy; 1994 Sep; 73(3):232-4. PubMed ID: 8092557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insect-sting challenge in 138 patients: relation between clinical severity of anaphylaxis and mast cell activation.
    van der Linden PW; Hack CE; Poortman J; Vivié-Kipp YC; Struyvenberg A; van der Zwan JK
    J Allergy Clin Immunol; 1992 Jul; 90(1):110-8. PubMed ID: 1629497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anaphylactic reaction to white-faced hornet sting and elevated baseline (asymptomatic) serum tryptase.
    Lieberman P; Schwartz LB
    J Allergy Clin Immunol Pract; 2013; 1(3):315. PubMed ID: 24565497
    [No Abstract]   [Full Text] [Related]  

  • 24. [Mastocytosis: an important differential diagnosis in anaphylactoid reaction to Hymenoptera sting. A case report and overview of clinical aspects, diagnosis and current therapy of mastocytosis].
    Bucher C; Simic P; Furrer J; Wüthrich B
    Praxis (Bern 1994); 2000 Mar; 89(10):411-8. PubMed ID: 10731856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity.
    Ruëff F; Przybilla B; Biló MB; Müller U; Scheipl F; Aberer W; Birnbaum J; Bodzenta-Lukaszyk A; Bonifazi F; Bucher C; Campi P; Darsow U; Egger C; Haeberli G; Hawranek T; Körner M; Kucharewicz I; Küchenhoff H; Lang R; Quercia O; Reider N; Severino M; Sticherling M; Sturm GJ; Wüthrich B
    J Allergy Clin Immunol; 2009 Nov; 124(5):1047-54. PubMed ID: 19895993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Usefulness of measurement of mast cell tryptase for differential diagnosis of anaphylaxis and anaphylactoid reaction].
    Saitoh J; Mitsuhata H; Horiguchi Y; Saitoh K; Fukuda H; Shimizu R
    Masui; 1995 Sep; 44(9):1265-8. PubMed ID: 8523664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histamine and tryptase levels in patients with acute allergic reactions: An emergency department-based study.
    Lin RY; Schwartz LB; Curry A; Pesola GR; Knight RJ; Lee HS; Bakalchuk L; Tenenbaum C; Westfal RE
    J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):65-71. PubMed ID: 10887307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human mast cell tryptase in biology and medicine.
    Vitte J
    Mol Immunol; 2015 Jan; 63(1):18-24. PubMed ID: 24793463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis.
    Schwartz LB; Sakai K; Bradford TR; Ren S; Zweiman B; Worobec AS; Metcalfe DD
    J Clin Invest; 1995 Dec; 96(6):2702-10. PubMed ID: 8675637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production.
    Butterfield JH; Weiler CR
    Int Arch Allergy Immunol; 2008; 147(4):338-43. PubMed ID: 18622141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tryptase, a mediator of human mast cells.
    Schwartz LB
    J Allergy Clin Immunol; 1990 Oct; 86(4 Pt 2):594-8. PubMed ID: 2229822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hymenoptera-induced anaphylaxis: is it a mast cell driven hematological disorder?
    Brockow K; Akin C
    Curr Opin Allergy Clin Immunol; 2017 Oct; 17(5):356-362. PubMed ID: 28796123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The presence of mast cell clonality in patients with unexplained anaphylaxis.
    Gülen T; Hägglund H; Sander B; Dahlén B; Nilsson G
    Clin Exp Allergy; 2014 Sep; 44(9):1179-87. PubMed ID: 25039926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mast cell activation syndromes presenting as anaphylaxis.
    Akin C
    Immunol Allergy Clin North Am; 2015 May; 35(2):277-85. PubMed ID: 25841551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characteristics and risk profile of patients with elevated baseline serum tryptase.
    Fellinger C; Hemmer W; Wöhrl S; Sesztak-Greinecker G; Jarisch R; Wantke F
    Allergol Immunopathol (Madr); 2014; 42(6):544-52. PubMed ID: 25224360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mast Cell Disorders In Drug Hypersensitivity.
    Bonadonna P; Bonifacio M; Zanotti R
    Curr Pharm Des; 2016; 22(45):6862-6869. PubMed ID: 27779084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of post mortem determination of serum tryptase, histamine and diamine oxidase in the diagnosis of fatal anaphylaxis.
    Mayer DE; Krauskopf A; Hemmer W; Moritz K; Jarisch R; Reiter C
    Forensic Sci Int; 2011 Oct; 212(1-3):96-101. PubMed ID: 21664082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acid hydrolases and tryptase from secretory granules of dispersed human lung mast cells.
    Schwartz LB; Lewis RA; Seldin D; Austen KF
    J Immunol; 1981 Apr; 126(4):1290-4. PubMed ID: 7009736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum concentration of baseline mast cell tryptase: evidence for a decline during long-term immunotherapy for Hymenoptera venom allergy.
    Dugas-Breit S; Przybilla B; Dugas M; Arnold A; Pfundstein G; Küchenhoff H; Ruëff F
    Clin Exp Allergy; 2010 Apr; 40(4):643-9. PubMed ID: 20100187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.